Vivoryon Therapeutics N.V. (AMS: VVY)
Netherlands
· Delayed Price · Currency is EUR 2.185
+0.010 (0.46%)
Jan 6, 2025, 9:13 AM CET
Vivoryon Therapeutics Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 15.27 | 18.56 | 26.56 | 14.66 | 26.31 | 41.52 | Upgrade
|
| Short-Term Investments | - | 10.02 | 0.01 | - | - | - | Upgrade
|
| Cash & Short-Term Investments | 15.27 | 28.58 | 26.56 | 14.66 | 26.31 | 41.52 | Upgrade
|
| Cash Growth | -60.42% | 7.61% | 81.17% | -44.27% | -36.65% | 997.65% | Upgrade
|
| Accounts Receivable | - | 0.5 | - | - | - | - | Upgrade
|
| Other Receivables | 0.33 | 0.51 | 3.97 | 3.36 | 0.13 | 0.6 | Upgrade
|
| Receivables | 0.33 | 1.01 | 3.97 | 3.36 | 0.13 | 0.6 | Upgrade
|
| Prepaid Expenses | 0.37 | 0.22 | 0.17 | 0.18 | 0.11 | 3.23 | Upgrade
|
| Other Current Assets | 0.07 | - | - | 2.03 | 2.25 | 0.02 | Upgrade
|
| Total Current Assets | 16.05 | 29.81 | 30.69 | 20.23 | 28.79 | 45.38 | Upgrade
|
| Property, Plant & Equipment | 0.04 | 0.08 | 0.18 | 0.29 | 0.39 | 0.47 | Upgrade
|
| Other Intangible Assets | 0.9 | 0.94 | 0.49 | 0.53 | 0.57 | 0.02 | Upgrade
|
| Other Long-Term Assets | - | - | 0.01 | 3.47 | 0 | 0 | Upgrade
|
| Total Assets | 16.99 | 30.83 | 31.38 | 24.52 | 29.75 | 45.86 | Upgrade
|
| Accounts Payable | 1.47 | 2.89 | 2.54 | 4.36 | 0.91 | 0.54 | Upgrade
|
| Accrued Expenses | 0.24 | 0.24 | 0.25 | 0.23 | 0.26 | 0.24 | Upgrade
|
| Current Portion of Leases | 0.01 | 0.04 | 0.09 | 0.09 | 0.09 | 0.09 | Upgrade
|
| Other Current Liabilities | 0 | 0.01 | 0.38 | 0.37 | 0.07 | 0.06 | Upgrade
|
| Total Current Liabilities | 1.71 | 3.18 | 3.27 | 5.05 | 1.33 | 0.93 | Upgrade
|
| Long-Term Leases | - | - | 0.04 | 0.13 | 0.22 | 0.32 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | - | 0.23 | 0.43 | - | - | Upgrade
|
| Other Long-Term Liabilities | 0.01 | 0.01 | 0.01 | 0.53 | - | - | Upgrade
|
| Total Liabilities | 3.01 | 4.55 | 4.87 | 7.96 | 3.53 | 3.2 | Upgrade
|
| Common Stock | 26.07 | 26.07 | 24.11 | 20.05 | 19.98 | 19.98 | Upgrade
|
| Additional Paid-In Capital | 135.67 | 135.67 | 113.38 | 83.21 | 82.14 | 82.14 | Upgrade
|
| Retained Earnings | -162.36 | -148.8 | -120.46 | -92.3 | -79.65 | -63.14 | Upgrade
|
| Comprehensive Income & Other | 14.6 | 13.34 | 9.48 | 5.6 | 3.75 | 3.68 | Upgrade
|
| Shareholders' Equity | 13.98 | 26.28 | 26.51 | 16.56 | 26.22 | 42.67 | Upgrade
|
| Total Liabilities & Equity | 16.99 | 30.83 | 31.38 | 24.52 | 29.75 | 45.86 | Upgrade
|
| Total Debt | 0.01 | 0.04 | 0.13 | 0.22 | 0.31 | 0.41 | Upgrade
|
| Net Cash (Debt) | 15.26 | 28.55 | 26.43 | 14.44 | 25.99 | 41.12 | Upgrade
|
| Net Cash Growth | -60.36% | 8.00% | 83.07% | -44.46% | -36.79% | 986.92% | Upgrade
|
| Net Cash Per Share | 0.60 | 1.13 | 1.20 | 0.72 | 1.30 | 3.28 | Upgrade
|
| Filing Date Shares Outstanding | 26.07 | 26.07 | 24.11 | 20.05 | 19.98 | 19.98 | Upgrade
|
| Total Common Shares Outstanding | 26.07 | 26.07 | 24.11 | 20.05 | 19.98 | 19.98 | Upgrade
|
| Working Capital | 14.34 | 26.63 | 27.43 | 15.18 | 27.47 | 44.45 | Upgrade
|
| Book Value Per Share | 0.54 | 1.01 | 1.10 | 0.83 | 1.31 | 2.14 | Upgrade
|
| Tangible Book Value | 13.08 | 25.34 | 26.01 | 16.02 | 25.66 | 42.65 | Upgrade
|
| Tangible Book Value Per Share | 0.50 | 0.97 | 1.08 | 0.80 | 1.28 | 2.14 | Upgrade
|
| Machinery | - | 0.13 | 0.12 | 0.11 | 0.18 | 1.08 | Upgrade
|
| Leasehold Improvements | - | - | - | - | - | 0.18 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.